Nanoagent-based three-method treatment for atherosclerosis: Combination of thermal, mechanical, and drug-based methods

Project description

A nanostructure-based combined treatment for atherosclerosis

Atherosclerosis (AS) is a medical condition associated with the build-up of cholesterol plaques in the lining of arteries. These become hard and narrow and may cause heart attack or stroke. The objective of the NanoTAS project funded by the Marie Skłodowska-Curie Actions programme is to develop a novel combined treatment of AS using nano-structured agents. The approach combines thermal and mechanical treatments with targeted release of anti-AS drugs. Researchers aim to decrease the inflammation in the blood vessels, break existing atherosclerotic plaques and achieve specific drug delivery. The NanoTAS strategy is expected to achieve optimal outcome for AS patients.

Fields of science

• engineering and technology › nanotechnology › nano-materials

Programme(s)

• HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme

Topic(s)

• HORIZON-MSCA-2021-PF-01-01 - MSCA Postdoctoral Fellowships 2021

Call for proposal

HORIZON-MSCA-2021-PF-01

See other projects for this call

Funding Scheme

MSCA-PF -

Coordinator

UNIVERSIDAD DE GRANADA

Net EU contribution

€ 165 312,96

Address

Cuesta Del Hospicio Sn
18071 Granada
Spain

Region

Andalucía › Granada

Activity type

Higher or Secondary Education Establishments

Links

Other funding

No data